EUVIMEDEUVIMED entdecken
Crossref

Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia

Reiji Yoshimura, Atsuko Ikenouchi, Yuki Konishi

Clinical Neuropsychopharmacology and Therapeutics · 2020

DOI: 10.5234/cnpt.11.43 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2020. Verfasst von Reiji Yoshimura und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Yoshimura, R., Ikenouchi, A., & Konishi, Y. (2020). Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.11.43

Vancouver

Yoshimura R, Ikenouchi A, Konishi Y. Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia. Clinical Neuropsychopharmacology and Therapeutics. 2020. doi:10.5234/cnpt.11.43

BibTeX
@article{Yoshimura2020,
  author = {Yoshimura, Reiji and Ikenouchi, Atsuko and Konishi, Yuki},
  title = {Improvement of persistent cenesthopathy and depersonalization after treatment with brexpiprazole in schizophrenia},
  journal = {Clinical Neuropsychopharmacology and Therapeutics},
  year = {2020},
  doi = {10.5234/cnpt.11.43}
}
Kostenlos starten →